logo

Aravive, Inc. (ARAV)



Trade ARAV now with
  Date
  Headline
11/19/2020 7:19:27 AM Aravive Receives Guidance From FDA On Phase 3 Trial Design For AVB-500
9/17/2020 7:07:12 AM Aravive Appoints Michael Rogers To Board
9/15/2020 7:27:26 AM Aravive Appoints Reshma Rangwala As Chief Medical Officer
4/9/2020 7:14:13 AM Aravive Announces Board Changes; Names Gail McIntyre CEO
12/20/2019 8:24:46 AM Aravive Begins Phase 2a Trial Of AVB-500 In Patients With Kidney Fibrosis
11/27/2019 8:48:40 AM Aravive Prices Public Offering Of 3.33 Mln Shares At $7.50/Shr
7/8/2019 7:10:11 AM Aravive: Independent Data Monitoring Committee Recommends Continuation Of Phase Ib Study Of AVB-500
7/8/2019 7:08:50 AM Aravive Says IDMC Recommends Continuation Of Phase Ib Study Of AVB-500
3/7/2019 4:13:00 PM Aravive Q4 Loss/share $4.82 Vs. Profit $5.20 Year Ago